Regulation of MT-MMPs by Trafficking in Cancer Cells
癌细胞贩运对 MT-MMP 的调节
基本信息
- 批准号:7163439
- 负责人:
- 金额:$ 22.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-12-05 至 2008-12-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAnimal ModelBackBenignBiological ModelsCell Surface ReceptorsCell membraneCell surfaceCellsChemopreventionChimera organismClathrin-Coated VesiclesCollagen Type ICytoplasmic TailDevelopmentDoctor of PhilosophyDown-RegulationDynaminEarly EndosomeEndocytosisEndopeptidasesEnzymesEpigenetic ProcessExcisionExtracellular MatrixGeneticGolgi ApparatusGrowthGrowth FactorInvadedInvasiveLeadLysosomesMT3 geneMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of prostateMatrix MetalloproteinasesMeasuresMediatingNeoplasm MetastasisPeptide HydrolasesPharmacotherapyPhenotypePlayProcessRecyclingRegulationResearch PersonnelRoleSeriesSpecimenTFAP2A geneTestingTimeTransmembrane DomainTumor Cell Invasioncancer cellcell growthextracellulargain of functionhuman MMP14 proteininsightlate endosomemembermembrane-type matrix metalloproteinasemutantneoplastic cellnovelproMMP-2programstrafficking
项目摘要
Our long term objective is to determine how membrane-type matrix metalloproteinases (MT-MMPs) regulate
tumor invasion and metastasis. Although matrix metalloproteinases (MMPs) have been implicated in the
progression of malignant cancer, the mechanism by which tumor cells deploy these destructive proteinases
remains unresolved. MT-MMPs are a subset of MMPs with transmembrane domains capable of focusing
these enzymes on plasma membrane against extracellular matrix (ECM) barriers, representing a novel
paradigm on how tumor cells deploy proteolytic activity during tumor invasion and metastasis. We have
recently demonstrated that MT1-MMP is regulated by endocytosis in clathrin- coated vesicles to control its
proteolytic activity on cell surface. We established that its cytoplasmic domain is required for endocytosis
and its removal gave rise to a gain-of-function mutant of this enzyme. This endocytosis-deficient mutant is
more potent than wild type MT1-MMP in promoting invasiveness in prostate cancer cells, suggesting that the
invasiveness of tumor cells can be regulated through the trafficking of MT-MMPs. Employing a chimera
between MT1-MMP and MT3-MMP, we obtained the first evidence that internalized MT-MMPs can be
recycled back to cell surface. In this application, we propose to integrate the studies of MT1-MMP and MT3-
MMP to test the hypothesis that tumor cells modulate their invasiveness by controlling the trafficking of MT-
MMPs through their cytoplasmic domains. First, we will define the trafficking of MT1-MMP and MT3-MMP
from cell surface to various intracellular compartmetns and characterize the impact of growth factors and
extracellular matrix on their trafficking. Secondly, we will define the role of cytoplasmic domains of MT1-
MMP and MT3-MMP in mediating their trafficking/recycling and characterize their interactions with cellular
components. Thirdly, we will define the regulatory role of trafficking on MT1-MMP and MT3-MMP mediated
cell growth and invasion within or through 3-dimensional type I collagen matrix. Results from these
approaches may yield insights on how tumor cells gain a growth and invasive advantage by regulating the
trafficking of MT-MMPs and such insights may lead to the development of novel drugs for therapy and
chemoprevention against cancer.
我们的长期目标是确定膜型基质金属蛋白酶(MT-MMP)如何调节
肿瘤侵袭和转移。尽管基质金属蛋白酶(MMP)与
恶性癌的进展,肿瘤细胞部署这些破坏性蛋白酶的机制
仍然无法解决。 MT-MMP是具有跨膜结构域的MMP的子集
这些酶在质膜上针对细胞外基质(ECM)屏障,代表一种新颖
关于肿瘤细胞在肿瘤浸润和转移过程中如何部署蛋白水解活性的范式。我们有
最近证明MT1-MMP受网状包包囊泡的内吞作用的调节,以控制其
细胞表面上的蛋白水解活性。我们确定其胞质结构域是内吞作用所必需的
它的去除引起了该酶的功能收益突变体。这种缺陷型突变体是
比野生型MT1-MMP在促进前列腺癌细胞的侵袭性方面更有效,这表明
肿瘤细胞的侵入性可以通过运输MT-MMP来调节。采用嵌合体
在MT1-MMP和MT3-MMP之间,我们获得了内部MT-MMP的第一个证据
回收回到细胞表面。在此应用中,我们建议整合MT1-MMP和MT3-的研究。
MMP检验以下假设:肿瘤细胞通过控制MT-的运输来调节其侵入性
MMP通过其细胞质结构域。首先,我们将定义MT1-MMP和MT3-MMP的贩运
从细胞表面到各种细胞内c骨,并表征生长因子和
细胞外基质的贩运。其次,我们将定义MT1-的细胞质结构域的作用
MMP和MT3-MMP介导其运输/回收利用并表征其与细胞的相互作用
成分。第三,我们将定义贩运在MT1-MMP和MT3-MMP介导的调节作用
I型I型胶原蛋白基质内或通过3维内或通过3维内部的细胞生长和侵袭。这些结果
方法可能会通过调节肿瘤细胞如何获得生长和侵入性优势的见解
贩运MT-MMP和此类见解可能导致开发用于治疗和
针对癌症的化学预防。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DUANQING PEI其他文献
DUANQING PEI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DUANQING PEI', 18)}}的其他基金
Tumor Invasion and Metastasis Mediated by Cell Surface Proteolysis
细胞表面蛋白水解介导的肿瘤侵袭和转移
- 批准号:
7213697 - 财政年份:2006
- 资助金额:
$ 22.54万 - 项目类别:
Tumor Invasion and Metastasis Mediated by Cell Surface Proteolysis
细胞表面蛋白水解介导的肿瘤侵袭和转移
- 批准号:
7479625 - 财政年份:2006
- 资助金额:
$ 22.54万 - 项目类别:
Tumor Invasion and Metastasis Mediated by Cell Surface Proteolysis
细胞表面蛋白水解介导的肿瘤侵袭和转移
- 批准号:
7289318 - 财政年份:2006
- 资助金额:
$ 22.54万 - 项目类别:
The Role of Matrix Metalloproteinases in Asthma and Allergy
基质金属蛋白酶在哮喘和过敏中的作用
- 批准号:
7041971 - 财政年份:2003
- 资助金额:
$ 22.54万 - 项目类别:
A NOVEL TYPE II TRANSMEMBRANE MATRIX METALLOPROTEINASE
一种新型 II 型跨膜基质金属蛋白酶
- 批准号:
6335941 - 财政年份:2000
- 资助金额:
$ 22.54万 - 项目类别:
STRUCTURE/FUNCTION OF METALLOPROTEINASE MT3/MMP
金属蛋白酶 MT3/MMP 的结构/功能
- 批准号:
6329007 - 财政年份:1997
- 资助金额:
$ 22.54万 - 项目类别:
Regulation of MT-MMPs by Trafficking in Cancer Cells
癌细胞贩运对 MT-MMP 的调节
- 批准号:
7009219 - 财政年份:1997
- 资助金额:
$ 22.54万 - 项目类别:
Regulation of MT-MMPs by Trafficking in Cancer Cells
癌细胞贩运对 MT-MMP 的调节
- 批准号:
6831638 - 财政年份:1997
- 资助金额:
$ 22.54万 - 项目类别:
STRUCTURE/FUNCTION OF METALLOPROTEINASE MT3/MMP
金属蛋白酶 MT3/MMP 的结构/功能
- 批准号:
2837774 - 财政年份:1997
- 资助金额:
$ 22.54万 - 项目类别:
STRUCTURE/FUNCTION OF METALLOPROTEINASE MT3/MMP
金属蛋白酶 MT3/MMP 的结构/功能
- 批准号:
2450610 - 财政年份:1997
- 资助金额:
$ 22.54万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
利用碱基编辑器治疗肥厚型心肌病的动物模型研究
- 批准号:82300396
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
利用小型猪模型评价动脉粥样硬化易感基因的作用
- 批准号:32370568
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
丁苯酞通过调节细胞异常自噬和凋亡来延缓脊髓性肌萎缩症动物模型脊髓运动神经元的丢失
- 批准号:82360332
- 批准年份:2023
- 资助金额:31.00 万元
- 项目类别:地区科学基金项目
APOBEC3A驱动膀胱癌发生发展的动物模型及其机制研究
- 批准号:82303057
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Personalized bioprinting technology for de novo PDL regeneration
用于 PDL 从头再生的个性化生物打印技术
- 批准号:
10667088 - 财政年份:2023
- 资助金额:
$ 22.54万 - 项目类别:
Super-resolved multiphoton microscopy with dual output ultrafast laser
具有双输出超快激光的超分辨率多光子显微镜
- 批准号:
10664267 - 财政年份:2023
- 资助金额:
$ 22.54万 - 项目类别:
Elucidating the role of pericytes in angiogenesis in the brain using a tissue-engineered microvessel model
使用组织工程微血管模型阐明周细胞在大脑血管生成中的作用
- 批准号:
10648177 - 财政年份:2023
- 资助金额:
$ 22.54万 - 项目类别:
Role of SMPDL3B in obesity-associated non-alcoholic fatty liver disease
SMPDL3B 在肥胖相关非酒精性脂肪肝中的作用
- 批准号:
10538925 - 财政年份:2022
- 资助金额:
$ 22.54万 - 项目类别:
Determining the role of reward circuits behind different paternal care behaviors and the motivation to care for offspring by comparing two animal models
通过比较两种动物模型来确定不同父亲照顾行为背后的奖励回路的作用以及照顾后代的动机
- 批准号:
10454008 - 财政年份:2022
- 资助金额:
$ 22.54万 - 项目类别: